Clinicoeconomics And Outcomes Research

SCIE

国际简称：CLINICOECONOMIC OUTC 参考译名：临床经济学和成果研究

主要研究方向：HEALTH CARE SCIENCES & SERVICES 非预警期刊审稿周期：16 Weeks

《临床经济学和成果研究》(Clinicoeconomics And Outcomes Research)是一本由Dove Medical Press出版的以HEALTH CARE SCIENCES & SERVICES为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊，近三年没有被列入预警名单。

4区中科院分区
Q2 JCR分区
73 年发文量
2.6 IF影响因子
未开放 是否OA
1 issue/year 出版周期
English 出版语言

Clinical economics and outcomes research focuses primarily on clinical trials, health economics, and outcome studies. The goal of this magazine is to provide a platform for clinical doctors, health economists, policy makers, healthcare decision-makers, and researchers to exchange and share research findings. The content of the magazine covers multiple fields such as clinical trials, health economics, outcome research, pharmacoeconomics, healthcare decision-making, healthcare policies, healthcare quality, and healthcare service research. These fields are currently hot topics in healthcare research and practice, and are of great significance for improving the quality and efficiency of healthcare. As an authoritative journal focusing on clinical economics and outcome research, it provides a platform for healthcare professionals to communicate and learn. By reading this magazine, readers can better understand how to effectively allocate medical resources and improve patient care quality in practical work.

[ 查看全部 ]

投稿咨询加急咨询

Clinicoeconomics And Outcomes Research期刊信息

ISSN：1178-6981
出版语言：English
是否OA：未开放
出版地区：United Kingdom
是否预警：否
出版商：Dove Medical Press
出版周期：1 issue/year
开源占比：0.9718
Gold OA文章占比：99.48%
OA被引用占比：1
出版国人文章占比：0.01
出版撤稿占比：
研究类文章占比：91.78%

Clinicoeconomics And Outcomes Research CiteScore评价数据（2026年6月最新版）

CiteScore

SJR

SNIP

CiteScore 指数

4.2

0.785

1.19

学科类别	分区	排名	百分位
大类：Economics, Econometrics and Finance 小类：Economics, Econometrics and Finance (miscellaneous)	Q1	64 / 283	77%
大类：Economics, Econometrics and Finance 小类：Health Policy	Q2	108 / 330	67%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Clinicoeconomics And Outcomes Research中科院评价数据

《新锐期刊分区表》（2026年3月发布）

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	HEALTH CARE SCIENCES & SERVICES 卫生保健与服务	4区

Clinicoeconomics And Outcomes Research JCR评价数据

2025-2026年最新版

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：HEALTH CARE SCIENCES & SERVICES	ESCI	Q2	89 / 194	54.4
学科：HEALTH CARE SCIENCES & SERVICES	ESCI	Q3	105 / 194	46.13

Clinicoeconomics And Outcomes Research历年数据统计

影响因子

中科院分区

Clinicoeconomics And Outcomes Research中国学者发文选摘

1、Effect of Drug Cost-Exemption Policy on Treatment Outcomes in Multidrug-Resistant Tuberculosis Patients in Guangxi Zhuang Autonomous Region, China: A Nested Case-Control Stud
Author: Liu, Aimei; Liao, Yan; Ye, Juexian; Wang, Qing; Huang, Junli; Tang, Yucheng; Feng, Lizhen

Journal: CLINICOECONOMICS AND OUTCOMES RESEARCH. 2026; Vol. 18, Issue , pp. -. DOI: 10.2147/CEOR.S577874
2、Association Between Willingness to Pay and Quality of Life in Acne Patients: A Cross-Sectional Study with a Nomogram for Individualized Predictio
Author: Li, Xiangzi; Cen, Xintao; Ning, Ning; Li, Chao; Zhu, Yaqian; Liu, Jiarui; Zhu, Qian; He, Shiyu; Guan, Yang

Journal: CLINICOECONOMICS AND OUTCOMES RESEARCH. 2026; Vol. 18, Issue , pp. -. DOI: 10.2147/CEOR.S579111
3、Pharmaceutical Manufacturing in China Innovation Performance: A Dynamic QCA Analysis Based on the WSR Perspectiv
Author: Zhu, Wangwang; Tao, Shiqi; Zhou, Xiaoying; Fu, Rui

Journal: CLINICOECONOMICS AND OUTCOMES RESEARCH. 2026; Vol. 18, Issue , pp. -. DOI: 10.2147/CEOR.S560908
4、The Economic Burden of Patients with Diabetic Peripheral Neuropathic Pain Based on a Real-World Study in Chin
Author: Wang, Rosa; Xuan, Dennis; Xuan, Jianwei; Dai, Dong; Ye, Xin; Hu, Xiaohan

Journal: CLINICOECONOMICS AND OUTCOMES RESEARCH. 2025; Vol. 17, Issue , pp. 437-446. DOI: 10.2147/CEOR.S501243
5、Health Economics Evaluation of Bictegravir/ Emtricitabine/Tenofovir for a First-Line Treatment of HIV-1 Infection in Chin
Author: Wang, Wenjuan; Zhou, Dachuang; Zhou, Kejia; Zhang, Di; Li, Hao; Zhang, Hongliu; Jiang, Xin; Wang, Ruihua; Wang, Xi; Tang, Wenxi

Journal: CLINICOECONOMICS AND OUTCOMES RESEARCH. 2025; Vol. 17, Issue , pp. 393-406. DOI: 10.2147/CEOR.S513601